Improving Cardiovascular Risk in Postmenopausal Women with an (-)-Epicatechin-Based Nutraceutical: A Randomly Assigned, Double-Blind vs. Placebo, Proof-of-Concept Trial.

J Clin Med · 2023 · PMC10779966 · PMID 38202201

Europe PMC DOI

hedged sentence

0.0926

closest p · 1.9× alpha

0.0926

boldest claim

The sentences

did not reach statistical significancep = 0.0926so close (0.05 < p ≤ 0.1)

Even when this result did not reach statistical significance ( p = 0.0926), it represented a 41% decrease in the oxidative damage status ( Table 3 ). 4.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.